Current openings at Yarrow Biotechnology

Yarrow Biotechnology is an early-stage biotechnology company focused on developing therapeutics for auto-immune and metabolic diseases. Our targets and approaches stem from the knowledge and discoveries in the fields of human biology, pharmacology, and genetics. Our primary focus is the discovery and development of safe and efficacious antibodies to address significant unmet need and improve patient and caregiver experience. Our lead program is for the treatment of an autoimmune disease with the potential to be the first- and best-in-class disease-modifying therapy in multiple indications. 

Yarrow Biotechnology is the latest company founded by RTW Investments, a global, full life-cycle investment firm. RTW has over a decade of experience supporting transformative healthcare companies including many developing first-in-class genetic therapies. RTW founded Rocket Pharma (NASDAQ: RCKT), one of the largest gene therapy companies with a pipeline that includes 4 first-in-class clinical programs and JIXING Pharmaceuticals, a leading biotech company headquartered in Shanghai developing and commercializing novel, innovative therapeutics including 4 cardiovascular programs and 4 ophthalmology assets.